Docaravimab + Miromavimab

Docaravimab+Miromavimab is used in the treatment of Rabies.

Rabies is a viral infection caused by the rabies virus, which primarily affects the nervous system. Once the rabies virus enters the body through a bite from an infected animal, it travels along nerve fibers to the central nervous system, including the brain. There, it can cause severe neurological symptoms and, ultimately, death if left untreated. Docaravimab + Miromavimab ontains two antibodies: Docaravimab and Miromavimab. These antibodies bind to the rabies virus. By binding to the virus, they prevent it from entering and infecting nerve cells and other cells in the body. This interruption of the virus's ability to replicate and spread within the body is crucial in halting the progression of rabies.